What You Should Know:
– Click Therapeutics, a leader in prescription digital therapeutics (DTx), announced today the acquisition of key assets from Better Therapeutics.
– Click’s expansion into cardiometabolic disease follows successful DTx development efforts in…
Continue Reading
Paige, a global leader in digital pathology solutions, has received the FDA’s Breakthrough Device Designation for Paige Lymph Node. This AI application is a pioneering tool for detecting breast cancer metastases in lymph nodes….
Continue Reading
What You Should Know: Annalise.ai, a leader in AI-powered medical imaging solutions, announced the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the triage and notification of obstructive hydrocephalus (OHCP)…
Continue Reading
British company Ultromics has been granted FDA Breakthrough Device Status for its artificial intelligence (AI)-enhanced platform for detecting cardiac amyloidosis.EchoGo Amyloidosis uses AI technology to analyse echocardiograms to detect the presence of cardiac amyloidosis….
Continue Reading
